Health Care [ 8/12 ] | Pharmaceuticals [ 29/73 ]
NASDAQ | Common Stock
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.
It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels.
The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Reported date | EPSChange YoY | EstimateSurprise |
---|---|---|
May 5, 25 | -0.17 Decreased by -88.89% | -0.10 Decreased by -70.00% |
Mar 4, 25 | 0.01 Increased by +111.58% | 0.02 Decreased by -37.67% |
Nov 6, 24 | -0.16 Increased by 0.00% | -0.10 Decreased by -60.00% |
Jul 31, 24 | -0.04 Increased by +78.95% | -0.05 Increased by +20.00% |
May 7, 24 | -0.09 Increased by +40.00% | -0.10 Increased by +10.00% |
Mar 7, 24 | -0.12 Increased by +14.29% | -0.07 Decreased by -71.43% |
Nov 7, 23 | -0.16 Increased by +42.86% | -0.17 Increased by +5.88% |
Aug 2, 23 | -0.19 Increased by +32.14% | -0.19 |
Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
---|---|---|---|
Mar 31, 25 | 68.07 M Increased by +14.73% | -18.89 M Decreased by -44.11% | Decreased by -27.75% Decreased by -25.61% |
Dec 31, 24 | 78.95 M Increased by +29.42% | -6.79 M Increased by +42.60% | Decreased by -8.60% Increased by +55.65% |
Sep 30, 24 | 61.09 M Increased by +23.85% | -19.17 M Decreased by -13.28% | Decreased by -31.38% Increased by +8.53% |
Jun 30, 24 | 66.91 M Increased by +35.59% | -11.35 M Increased by +37.43% | Decreased by -16.96% Increased by +53.85% |
Mar 31, 24 | 59.33 M Increased by +42.21% | -13.11 M Increased by +11.37% | Decreased by -22.09% Increased by +37.68% |
Dec 31, 23 | 61.00 M Increased by +39.76% | -11.83 M Increased by +10.13% | Decreased by -19.40% Increased by +35.69% |
Sep 30, 23 | 49.32 M Increased by +45.50% | -16.92 M Increased by +16.54% | Decreased by -34.31% Increased by +42.64% |
Jun 30, 23 | 49.35 M Increased by +32.78% | -18.14 M Increased by +22.71% | Decreased by -36.76% Increased by +41.79% |